Pharmaceutical companies readying legal strategies to oppose US government’s Medicare drug…
Pharmaceutical firms are setting the legal framework to oppose the US intention to negotiate medication pricing for Medicare health coverage.
The Inflation Reduction Act (IRA), a key drug pricing reform of the Biden administration, aims…